These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [On the possibility of avoiding "untoward" effects of cortisone therapy by means of the mixed administration of prednisone-glutathione]. RIGGIO T, BELLAFIORE V. Ann Ital Dermatol Sifilogr; 1959; 14():286-312. PubMed ID: 13741619 [No Abstract] [Full Text] [Related]
24. [Protection of the adrenal cortex during prolonged cortisone treatment]. TURIAF J, ZIZINE L, JEANJEAN Y. Vie Med; 1954 Dec; 35(Spec No.):98-100. PubMed ID: 14359690 [No Abstract] [Full Text] [Related]
35. [Digestive complications during adrenal cortex hormone therapy]. MOZZICONACCI P, ATTAL C, GIRARD F, HABIB R, HAYEM F. Sem Hop; 1958 Dec 24; 34(59/12):3179-90P. PubMed ID: 13624761 [No Abstract] [Full Text] [Related]
36. [The effects on the blood circulation of adrenal cortex hormones]. HOFFMANN G, EMMRICH J. Verh Dtsch Ges Kreislaufforsch; 1959 Dec 24; 25():108-11. PubMed ID: 13852450 [No Abstract] [Full Text] [Related]
37. [Prevention by testosterone of adrenal atrophy produced by cortisone treatment]. TURIAF J, ZIZINE L, JEANJEAN Y. Presse Med (1893); 1953 Jun 10; 61(40):825-6. PubMed ID: 13088719 [No Abstract] [Full Text] [Related]
38. [Cortisone diabetes and diabetes in dermatology and leprosy]. El Amile A. Maroc Med; 1974 May 10; 54(579):294-303. PubMed ID: 4444312 [No Abstract] [Full Text] [Related]
39. [The problem of corticosteroid allergy (author's transl)]. Gutzwiller P. Dermatologica; 1974 May 10; 148(4):253-6. PubMed ID: 4849945 [No Abstract] [Full Text] [Related]
40. [Effect of hydrochloric hydrolysis and of fermentation on structure of cortisone and of urinary corticoids]. DEMEY E, VIVARIO R, HEUSGHEM C, TARTE M, VLIERS M, VAN CAUWENBERGE H. Ann Endocrinol (Paris); 1955 May 10; 16(4):655-66. PubMed ID: 13327421 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]